Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity

Obesity

Volumn 21, Issue 9, 2013, Pages 1935-1941

  Guichelaar, M M J ^a,b   Gawrieh, S ^c   Olivier, M ^c   Viker, K ^b   Krishnan, A ^b   Sanderson, S ^b   Malinchoc, M ^b   Watt, K D ^b   Swain, J M ^b   Sarr, M ^b   Charlton, M R ^b  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b MAYO CLINIC   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PNLPA3 GENE; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; ALLELES; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 1; FATTY LIVER; FEMALE; FIBRINOGEN; FIBROSIS; GENETIC VARIATION; GENOTYPE; HUMANS; INSULIN RESISTANCE; LIPASE; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY, MORBID; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84884909122     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20327     Document Type: Article

References (31)

1. Angulo P, Keach JC, Batts KP, Lindor KD,. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362.
2. Luyckx FH, Lefebvre PJ, Scheen AJ,. Non-alcoholic steatohepatitis: association with obesity and insulin resistance and influence of weight loss. Diabetes Metab 2000; 26: 98-106.
3. Dixon JB, Bhathal PS, O'Brien PE,. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.
4. Shields M, Carrol MD, Ogden CL,. Adult obesity prevalence in Canada and the United States. NHCS Data Brief 2011; 56: 1-8.
5. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395.
6. Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-1465.
7. Yuan X, Waterworth D, Perry JER, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 2008; 83: 520-528.
8. Valenti L, Al-Serri A, Daly AK, et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1209-1217.
9. Sookoian S, Castano GO, Burhueno AL, et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 2009; 50: 2111-2116.
10. Kantartzis K, Peter A, Machicao F, et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 2009; 58: 2616-2623.
11. Kotronen A, Peltonen M, Hakkarainen A, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 2009; 137: 865-872.
12. Kotronen A, Johansson LE, Johansson LM, et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 2009; 52: 1056-1060.
13. Rotman Y, Koh C, Zmuda JM, et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010; 52: 894-903.
14. Hotta K, Yoneda M, Hyogo H, et al. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med Genet 2010; 11: 1-10.
15. Sokooian S, Pirola CJ,. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011; 53: 1883-1894.
16. Tian C, Stokowski RP, Kershenobich D, et al. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 2010; 42: 21-23.
17. Stickel F, Buch S, Lau K, et al. Genetic variation in the PNPLA3 gene with alcoholic liver injury in Caucasians. Hepatology 2011; 53: 86-95.
18. Valenti L, Rumi M, Galmozzi E, et al. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology 2011; 53: 791-799.
19. Johansson LE, Lindblad U, Larsson CA, et al. Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity. Eur J Endocrinol 2008; 159: 577-583.
20. Steinberg GR, Kemp BE, Watt MJ,. Adipocyte triglyceride lipase expression in human obesity. Am J Physiol Endocrinol Metab 2007; 293: E958-E964.
21. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
22. Romeo S, Sentinelli F, Dash S, et al. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes (Lond) 2010; 34: 190-194.
23. Lacke AC, Sun Y, Li JL, et al. Expression, regulation and triglyceride hydroxylase activity of adiponutrin family members. J Lipid Res 2005; 46: 2477-2487.
24. 2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 2004; 279: 48968-48975.
25. Chen L, Chang B, Li L, Chan L,. PNPLA3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 2010; 52: 1134-1142.
26. He S, McPhaul C, Li JZ, et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010; 285: 6706-6715.
27. Polson DA, Thompon MP,. Adiponutrin mRNA expression in white adipose tissue is rapidly induced by meal-feeding a high sucrose diet. Biochem Biophys Res Commun 2003; 301: 261-266.
28. Moldes M, Beauregard G, Faraj M, et al. Adiponutrin gene is regulated by insulin and glucose in human adipose tissue. Eur J Endocrinol 2006; 155: 461-468.
29. Steinberg GR, Kemp BE, Watt MJ,. Adipocyte triglyceride lipase expression in human obesity. Am J Physiol Endocrinol Metab 2007; 293: E958-E964.
30. Davis JN, Le KR, Walker RW, et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr 2010; 92: 1522-1527.
31. Johansson LE, Johansson LM, Danielsson P, et al. Genetic variance in the adiponutrin gene family and childhood obesity. PloS One 2009; 4: e5327. Diseases Diseases